default author photo

Julià Blanco

IrsiCaixa

SCHOLARLY PAPERS

2

DOWNLOADS

175

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Humoral and Cellular Immune Responses after a Heterologous SARS-CoV-2 Booster with the Protein-Based PHH-1V Vaccine in People with Immunocompromising Conditions: The RBDCOV HIPRA-HH-4 Study

Number of pages: 54 Posted: 21 Jul 2025
Autonomous University of Barcelona - Hospital Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Institut d'Investigacions Biomèdiques August Pi Sunyer, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department, Hospital Germans Trias i Pujol - Fundació Lluita contra les Infeccions, Hospital of Girona “Dr. Josep Trueta” - Institut d’Investigació Biomédica de Girona (IdIBGi), Institut d'Investigacions Biomèdiques August Pi Sunyer, MetPharm Arastirma Gelistirme Saglik Danismanlık, Autonomous University of Barcelona - Hospital Germans Trias i Pujol, Institut d'Investigacions Biomèdiques August Pi Sunyer, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Institut d'Investigacions Biomèdiques August Pi Sunyer, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, European AIDS Treatment Group (EATG), Hospital of Girona “Dr. Josep Trueta” - Institut d’Investigació Biomédica de Girona (IdIBGi), Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Institut d'Investigacions Biomèdiques August Pi Sunyer, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, IrsiCaixa, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute and IrsiCaixa AIDS Research Institute-HIVACAT
Downloads 106 (659,652)

Abstract:

Loading...

SARS-COV-2 Vaccines, HIPRA SARS-COV-2 Vaccine, Antibodies, Neutralizing, CD4-Positive T-Lymphocytes, Immunoglobulin G, Immunization, Primary Immunodeficiency Diseases, HIV, Transplantation

2.

Blinded 2-Year Longitudinal Evaluation of SARS-CoV-2 Antigenemia in Long COVID

Number of pages: 24 Posted: 06 Nov 2025
Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department, Harvard University, Hospital Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department, Hospital Germans Trias i Pujol, Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department, Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department, IrsiCaixa, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Hospital Germans Trias i Pujol, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, IrsiCaixa, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute, IrsiCaixa, AstraZeneca Pharmaceuticals, Hospital Universitari Germans Trias i Pujol - Biostatistics Unit, Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department, Harvard University - Department of Pathology and Hospital Universitari Germans Trias i Pujol - IrsiCaixa AIDS Research Institute
Downloads 69 (883,195)

Abstract:

Loading...

Long COVID, Post-COVID-19 condition, Post-acute Sequelae of SARS-CoV-2 (PASC), antigenemia, SARS-CoV-2 persistence